A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis
Clinical trial NCT00236028 · COMPLETED
Trial details
- NCT number
- NCT00236028
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 607
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.